Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches

In December 2019, a new variant of SARS-CoV emerged, the so-called acute severe respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus causes the new coronavirus disease (COVID-19) and has been plaguing the world owing to its unprecedented spread efficiency, which has resulted in a huge death t...

Descripción completa

Detalles Bibliográficos
Autores principales: Batalha, Pedro N., Forezi, Luana S.M., Lima, Carolina G.S., Pauli, Fernanda P., Boechat, Fernanda C.S., de Souza, Maria Cecília B.V., Cunha, Anna C., Ferreira, Vitor F., da Silva, Fernando de C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676325/
https://www.ncbi.nlm.nih.gov/pubmed/33261844
http://dx.doi.org/10.1016/j.bioorg.2020.104488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676325/
https://www.ncbi.nlm.nih.gov/pubmed/33261844
http://dx.doi.org/10.1016/j.bioorg.2020.104488

Ejemplares similares